MBOT (microbotmedical.com) Total Enterprise Value

Official company branding of Microbot Medical, Inc (MBOT)

Microbot Medical Inc. (MBOT) develops LIBERTY disposable surgical robots, whose patents block competitors amid stringent FDA oversight. This price chart confirms a market valuation of -4.25. High barriers to entry are maintained by the precision of micro-system control and the complexity of personnel training. Simultaneously, the company is implementing automated assembly lines and testing AI algorithms for the management of steerable microcatheters.

MBOT (Microbot Medical Inc) Total Company Value history from 11/23/2025 to 10/27/2026

MBOT (Microbot Medical Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart Microbot Medical, Inc.|MBOT - Price Target Chart
- market capitalization data:
Market Value Microbot Medical|MBOT - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Microbot Medical|MBOT - Company Book Value|Market Cap to Net Assets Ratio microbotmedical.com|MBOT - Company Total Assets
- debt and liquidity data:
Debt to Capital Microbot Medical Inc.|MBOT - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio microbotmedical.com|MBOT - Company Aggregate Debts|Debts to Net Assets Microbot Medical
General company analysis:MBOT (Microbot Medical, Inc.)
Original product of Microbot Medical, Inc.

Enterprise value, calculated as the sum of market capitalization and net debt, determines the actual acquisition price of a business by excluding the influence of the financing structure. The current value of -4.25, reflected in the total business valuation metric, allows investors to correlate financial expenditures with the engineering development potential of Microbot Medical Inc. (MBOT) in the field of robotic surgery.

Competitor analysis for Microbot Medical Inc.

Intuitive Surgical, Inc. - Total Company Value|DHR (Danaher Corp) - Total Company Value|Becton Dickinson & Company (BDX) - Total Enterprise Value|STE - Real Price to Acquire Entire Company|WST (westpharma.com) - Aggregate Business Value|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Teknova Inc TKNO|Enterprise Value MGRM (Monogram Technologies)|STSS: Company Buyout Price|Total Company Value infusystem.com|UTMD (Utah Medical Products Inc.) - Business Value|KRMD: Total Company Value|Company Buyout Price Nyxoah S.A (NYXH)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)